murlentamab (GM102)

murlentamab · GamaMabs Pharma

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for murlentamab (GM102), covering 2022-04-14 to 2022-04-14. Get the full timeline:

Most recent: Clinical Trial Update: Study for Evaluation of Murlentamab (GM102) Anti-tumoral Activity in Colorectal Cancers [Phase 2]